Cliff Asness's NRIX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 179,464 shares of Nurix Therapeutics, Inc. (NRIX) worth $4.35 M, representing 0.00% of the portfolio. First purchased in 2023-Q4, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in NRIX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 163,058 shares. Largest reduction occurred in Q1 2025, reducing 59,193 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Nurix Therapeutics (NRIX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Nurix Therapeutics (NRIX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +163,058 | Add 993.89% | 179,464 | $24.26 |
| Q1 2026 | +16,406 | New Buy | 16,406 | $15.50 |
| Q2 2025 | -11,668 | Sold Out | 0 | $0.00 |
| Q1 2025 | -59,193 | Reduce 83.53% | 11,668 | $11.88 |
| Q4 2024 | +23,941 | Add 51.03% | 70,861 | $18.84 |
| Q3 2024 | +25,624 | Add 120.32% | 46,920 | $22.47 |
| Q2 2024 | +9,254 | Add 76.85% | 21,296 | $20.87 |
| Q1 2024 | -15,414 | Reduce 56.14% | 12,042 | $14.70 |
| Q4 2023 | +27,456 | New Buy | 27,456 | $10.32 |
Cliff Asness's Nurix Therapeutics Investment FAQs
Cliff Asness first purchased Nurix Therapeutics, Inc. (NRIX) in Q4 2023, acquiring 27,456 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Nurix Therapeutics, Inc. (NRIX) for 9 quarters since Q4 2023.
Cliff Asness's largest addition to Nurix Therapeutics, Inc. (NRIX) was in Q2 2026, adding 179,464 shares worth $4.35 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 179,464 shares of Nurix Therapeutics, Inc. (NRIX), valued at approximately $4.35 M.
As of the Q2 2026 filing, Nurix Therapeutics, Inc. (NRIX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Nurix Therapeutics, Inc. (NRIX) was 179,464 shares, as reported at the end of Q2 2026.